pharma news today glp-1 obesity drugs

pharma news today glp-1 obesity drugs october 2025 trends 2025: real-world data, patient outcomes & future therapies Pharma Giants Bet on Next-Generation – The Disruptive Power of Weight

Name: pharma news today glp-1 obesity drugs october 2025 trends 2025: real-world data, patient outcomes & future therapies Pharma Giants Bet on Next-Generation – The Disruptive Power of Weight
Brand: kahaniyokasansar.com
SKU: 49837569124
Price: 23.75 USD
Availability: InStock
Rating: 4.432 (22 reviews)

SKU: 49837569124

4.4

EUR23.75 EUR48.75

Pay in 4 interest-free payments of $5.94 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

Description

Boehringer Ingelheim agreed to pay Yuhan $40 million upfront, of which $10 million will come after a preclinical toxicity test

Targeting or modifying agents chemically bound to the active ingredient A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g

Retinoids override that regulatory mechanism

Lau DCW et al

In recent years, the treatment landscape for obesity has evolved rapidly, with GLP-1 (glucagon-like peptide-1) agonists emerging as a powerful tool in weight management